Ben-Ari Alon, Chansky Howard, Rozet Irene
1Department of Anesthesiology and Pain Medicine (A.B.-A. and I.R.) and Department of Orthopaedic Surgery and Sports Medicine (H.C.), VA Puget Sound Health Care System, University of Washington, Seattle, Washington.
J Bone Joint Surg Am. 2017 Jan 4;99(1):1-9. doi: 10.2106/JBJS.16.00167.
Opioid use is endemic in the U.S. and is associated with morbidity and mortality. The impact of long-term opioid use on joint-replacement outcomes remains unknown. We tested the hypothesis that use of opioids is associated with adverse outcomes after total knee arthroplasty (TKA).
We performed a retrospective analysis of patients who had had TKA within the U.S. Veterans Affairs (VA) system over a 6-year period and had been followed for 1 year postoperatively. The length of time for which an opioid had been prescribed and the morphine equivalent dose were calculated for each patient. Patients for whom opioids had been prescribed for >3 months in the year prior to the TKA were assigned to the long-term opioid group. A natural language processing-based machine-learning classifier was developed to classify revisions due to infectious and non-infectious causes on the basis of the postoperative note. Survival curves for the time to knee revision or manipulation were used to compare the long-term opioid group with the patients who did not take opioids long-term. Hazard and odds ratios for knee revision and manipulation were obtained as well.
Of 32,636 patients (94.4% male; mean age [and standard deviation], 64.45 ± 9.41 years) who underwent TKA, 12,772 (39.1%) were in the long-term opioid group and 734 (2.2%) had a revision within a year after the TKA. Chronic kidney disease, diabetes, and long-term opioid use were associated with revision within 1 year-with odds ratios (95% confidence intervals [CIs]) of 1.76 (1.37 to 2.22), 1.11 (0.93 to 1.31), and 1.40 (1.19 to 1.64), respectively-and were also the leading factors associated with a revision at any time after the index TKA-with odds ratios (95% CIs) of 1.61 (1.34 to 1.92), 1.21 (1.08 to 1.36), and 1.28 (1.15 to 1.43), respectively. Long-term opioid use had a hazard ratio of 1.19 (95% CI = 1.10 to 0.24) in the analysis of its relationship with knee revision, but the hazard was not significant in the analysis of its association with knee manipulation. The accuracy of the text classifier was 0.94, with the area under the receiver operating characteristic curve being 0.99. There was no association between long-term use of opioids and the specific cause for knee revision.
Long-term opioid use prior to TKA was associated with an increased risk of knee revision during the first year after TKA among predominantly male patients treated in the VA system.
Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
阿片类药物在美国广泛使用,且与发病率和死亡率相关。长期使用阿片类药物对关节置换手术结果的影响尚不清楚。我们检验了以下假设:使用阿片类药物与全膝关节置换术(TKA)后的不良结果相关。
我们对在美国退伍军人事务(VA)系统内6年内接受TKA且术后随访1年的患者进行了回顾性分析。计算了每位患者的阿片类药物处方时长和吗啡等效剂量。在TKA前一年阿片类药物处方时长超过3个月的患者被归入长期阿片类药物组。开发了一种基于自然语言处理的机器学习分类器,根据术后记录对感染性和非感染性原因导致的翻修进行分类。使用膝关节翻修或手法治疗时间的生存曲线来比较长期阿片类药物组和未长期服用阿片类药物的患者。还获得了膝关节翻修和手法治疗的风险比及优势比。
在32636例接受TKA的患者中(94.4%为男性;平均年龄[及标准差]为64.45±9.41岁),12772例(39.1%)属于长期阿片类药物组,734例(2.2%)在TKA后一年内进行了翻修。慢性肾病、糖尿病和长期使用阿片类药物与1年内翻修相关,优势比(95%置信区间[CI])分别为1.76(1.37至2.22)、1.11(0.93至1.31)和1.40(1.19至1.64),并且也是首次TKA后任何时间翻修的主要相关因素,优势比(95%CI)分别为1.61(1.34至1.92)、1.21(1.08至1.36)和1.28(1.15至1.43)。在分析长期使用阿片类药物与膝关节翻修的关系时,其风险比为1.19(95%CI = 1.10至0.24),但在分析其与膝关节手法治疗的关联时,该风险不显著。文本分类器的准确率为0.94,受试者操作特征曲线下面积为0.99。长期使用阿片类药物与膝关节翻修的具体原因之间无关联。
在VA系统接受治疗的以男性为主的患者中,TKA前长期使用阿片类药物与TKA后第一年膝关节翻修风险增加相关。
治疗性III级。有关证据水平的完整描述,请参阅作者须知。